Research published today identifies potential new ways to treat the most common type of colorectal cancer in Ireland. The study, conducted by an international research team led by RCSI University of Medicine and Health Sciences and The Institute of Cancer Research, London, provides a roadmap for repurposing existing drugs and developing new ones to create more effective, personalized treatments for thousands of patients who currently have limited options.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | New study reveals how blood cancers outsmart BTK-targeted therapies | 0 | 8.1 | 28-07-2026 |
| 2 | Promising new options for treating aggressive prostate cancer | 7 | 8 | 18-10-2023 |
| 3 | Enhanced CAR T-cell therapy shows early promise for B-cell cancers in first-in-human trial | 0 | 13.29 | 13-10-2026 |
| 4 | Una esperanza contra la metástasis del cáncer colorrectal | 0 | 7.2 | 24-10-2026 |
| 5 | Study reveals how cancer cells survive chemotherapy in a zombie-like state | 0 | 10.36 | 24-10-2026 |
| 6 | Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases | 0 | 7 | 03-07-2026 |
| 7 | Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival | 0 | 7.13 | 04-06-2026 |
| 8 | Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer | 0 | 7 | 22-08-2024 |
| 9 | FDA approves groundbreaking new pancreatic cancer drug | 0 | 7.77 | 26-08-2026 |